244. Smith NT, Dec-Silver H, Sanford TJ Jr, et al: EEGs
during high-dose fentanyl-, sufentanil-, or morp-
hine-oxygen anesthesia. Anesth Analg 63:386-393,
1984.
245. Tempelhoff R, Modica PA, Bernardo KL, et al: Fen-
tanyl-induced electrocorticographic seizures in
patients with complex partial epilepsy. J Neurosurg
77:201-208, 1992.
246. Cascino GD, So EL, Sharbrough FW, et al: Alfenta-
nil-induced epileptiform activity in patients with
partial epilepsy. J Clin Neurophysiol 10:520-525,
1993.
247. Astrup J, Symon L, Branston NM, et al: Cortical
evoked potential and extracellular K
+
and H
+
at
critical levels of brain ischemia. Stroke 8:51-57,
1977.
248. Branston NM, Symon L, Crockard HA, et al: Rela-
tionship between the cortical evoked potential and
local cortical blood flow following acute middle
cerebral artery occlusion in the baboon. Exp Neurol
45:195-208, 1974.
249. Jones TH, Morawetz RB, Crowell RM, et al: Thres-
holds of focal cerebral ischemia in awake monkeys.
J Neurosurg 54:773-782, 1981.
250. Michenfelder JD, Sundt TM, Fode N, et al: Isoflu-
rane when compared to enflurane and halothane
decreases the frequency of cerebral ischemia during
carotid endarterectomy.Anesthesiology 67:336-340,
1987.
251. Hossmann KA: Viability thresholds and the penum-
bra of focal ischemia. Ann Neurol 36:557-565, 1994.
252. Sundt TM Jr, Sharbrough FW, Piepgras DG, et al:
Correlation of cerebral blood flow and electroen-
cephalographic changes during carotid endarterec-
tomy with results of surgery and hemodynamics of
cerebral ischemia. Mayo Clin Proc 56:533-543,
1981.
253. Michenfelder JD, Sundt TM Jr: Cerebral ATP and
lactate levels in the squirrel monkey following
occlusion of the middle cerebral artery. Stroke
2:319-326, 1971.
254. Michenfelder JD, Theye RA: The effects of anesthe-
sia and hypothermia on canine cerebral ATP and
lactate during anoxia produced by decapitation.
Anesthesiology 33:430-439, 1970.
255. Siesjo BK: Pathophysiology and treatment of focal
cerebral ischemia. Part I: Pathophysiology. J Neuro-
surg 77:169-184, 1992.
256. Lipton P: Ischemic cell death in brain neurons. Phys
Rev 79:1431-1568, 1999.
257. Fiskum G, Murphy AN, Beal MF: Mitochondria in
neurodegeneration: Acute ischemia and chronic
neurodegenerative diseases. J Cereb Blood Flow
Metab 19:351-369, 1999.
258. Velier JJ, Ellison JA, Kikly KK, et al: Caspase-8 and
caspase-3 are expressed by different populations of
cortical neurons undergoing delayed cell death
after focal stroke in the rat. J Neurosci 19:5932-
5941, 1999.
259. Kawaguchi M, Kimbro JR, Drummond JC, et al:
Isoflurane delays but does not prevent cerebral
infarction in rats subjected to focal ischemia. Anes-
thesiology 92:1335-1342, 2000.
260. Zauner A, Daugherty WP, Bullock MR, et al: Brain
oxygenation and energy metabolism: Part I—biolo-
gical function and pathophysiology. Neurosurgery
51:289-301, 2002.
261. Mattson MP, Duan W, Pedersen WA, et al: Neuro-
degenerative disorders and ischemic brain diseases.
Apoptosis 6:69-81, 2001.
262. Dirnagl U, Iadecola C, Moskowitz M: Pathobiology
of ischaemic stroke: An integrated view. Trends
Neurosci 22:391-397, 1999.
263. Abramson NA: Randomized clinical study of thio-
pental loading in comatose survivors of cardiac
arrest. N Engl J Med 314:397-403, 1986.
264. Forsman M, Aarseth HP, Nordby HK, et al: Effects
of nimodipine on cerebral blood flow and cere-
brospinal fluid pressure after cardiac arrest: Corre-
lation with neurologic outcome. Anesth Analg
68:436-443, 1989.
265. Roine RO, Kaste M, Kinnunen A, et al: Nimodipine
after resuscitation from out-of-hospital ventricular
fibrillation. A placebo-controlled, double-blind,
randomized trial. JAMA 264:3171-3177, 1990.
266. A randomized clinical study of a calcium-entry
blocker (lidoflazine) in the treatment of comatose
survivors of cardiac arrest. Brain Resuscitation
Clinical Trial II Study Group. N Engl J Med
324:1225-1231, 1991.
267. Hypothermia after Cardiac Arrest Study Group:
Mild therapeutic hypothermia to improve the neu-
rologic outcome after cardiac arrest. N Engl J Med
346:549-656, 2002.
268. Hoffman WE, Cheng MA, Thomas C, et al: Cloni-
dine decreases plasma catecholamines and impro-
ves outcome from incomplete ischemia in the rat.
Anesth Analg 73:460-464, 1991.
269. Hoffman WE, Thomas C, Albrecht RF: The effect of
halothane and isoflurane on neurologic outcome
following incomplete cerebral ischemia in the rat.
Anesth Analg 76:279-283, 1993.
270. Smith AL, Hoff JT, Nielsen SL, et al: Barbiturate
protection in acute focal cerebral ischemia. Stroke
5:1-7, 1974.
271. Michenfelder JD, Milde JH, Sundt TM: Cerebral
protection by barbiturate anesthesia. Arch Neurol
33:345-350, 1976.
272. Nehls DG, Todd MM, Spetzler RF, et al: A compa-
rison of the cerebral protective effects of isoflu-
rane and barbiturates during temporary focal
ischemia in primates. Anesthesiology 66:453-464,
1987.
273. Nussmeier NA, Arlund C, Slogoff S: Neuropsychia-
tric complications after cardiopulmonary bypass:
Cerebral protection by a barbiturate. Anesthesio-
logy 64:165-170, 1986.
274. Shapiro HM: Barbiturates in brain ischaemia. Br J
Anaesth 57:82-95, 1985.
275. Warner DS, Takaoka S,Wu B, et al: Electroencepha-
lographic burst suppression is not required to elicit
maximal neuroprotection from pentobarbital in a
rat model of focal cerebral ischemia. Anesthesio-
logy 84:1475-1484, 1996.
276. Busto R, DietrichWD, Globus MY, et al: Small diffe-
rences in intraischemic brain temperature critically
determine the extent of ischemic neuronal injury.
J Cereb Blood Flow Metab 7:729-738, 1987.
277. Sano T, Drummond JC, Patel PM, et al: A compa-
rison of the cerebral protective effects of isoflurane
and mild hypothermia in a rat model of incom-
plete forebrain ischemia. Anesthesiology 76:221-
228, 1992.
278. Warner DS, Zhou J, Ramani R, et al: Reversible focal
ischemia in the rat: Effects of halothane, isoflurane,
and methohexital anesthesia. J Cereb Blood Flow
Metab 11:794-802, 1991.
279. Drummond JC, Cole DJ, Patel PM, et al: Focal cere-
bral ischemia during anesthesia with etomidate,
isoflurane, or thiopental: A comparison of the
extent of cerebral injury. Neurosurgery 37:742-748,
1995, discussion 748-749.
280. Cole DJ, Cross LM, Drummond JC, et al: Thiopen-
tone and methohexital, but not pentobarbitone,
reduce early focal cerebral ischemic injury in rats.
Can J Anaesth 48:807-814, 2001.
281. Baughman VL, Hoffman WE, Miletich DJ, et al:
Neurologic outcome in rats following incomplete
cerebral ischemia during halothane, isoflurane or
N
2
O. Anesthesiology 69:192-198, 1988.
282. Soonthan-Brant V, Patel PM, Drummond JC, et al:
Fentanyl does not increase brain injury after focal
cerebral ischemia in rats. Anesth Analg 88:49-55,
1999.
283. Mackensen GB, Nellgard B, Kudo M, et al: Peri-
ischemic cerebral blood flow (CBF) does not
explain beneficial effects of isoflurane on outcome
from near complete forebrain ischemia in rats.
Anesthesiology 93:1102-1106, 2000.
284. Nellgard B, Mackensen GB, Pineda J, et al: Anes-
thetic effects on cerebral metabolic rate predict
histologic outcome from near-complete forebrain
ischemia in the rat. Anesthesiology 93:431-436,
2000.
285. Kawaguchi M, Kimbro JR, Drummond JC, et al:
Effects of isoflurane on neuronal apoptosis in rats
subjected to focal ischemia. J Neurosurg Anesthe-
siol 12:385, 2000.
286. Sakai H, Sheng H, Yates RB, et al: Isoflurane provi-
des long-term protection against focal cerebral
ischemia in the rat.Anesthesiology 106:92-99, 2007,
discussion 8-10.
287. Warner DS, McFarlane C, Todd MM, et al: Sevoflu-
rane and halothane reduce focal ischemic brain
damage in the rat. Anesthesiology 79:985-992, 1993.
288. Werner C,Mollenberg O,Kochs E,et al: Sevoflurane
improves neurological outcome after incomplete
cerebral ischaemia in rats. Br J Anaesth 75:756-760,
1995.
289. Engelhard K, Werner C, Reeker W, et al: Desflurane
and isoflurane improve neurological outcome after
incomplete cerebral ischaemia in rats. Br J Anaesth
83:415-421, 1999.
290. Wilhelm S, Ma D, Maze M, et al: Effects of xenon
on in vitro and in vivo models of neuronal injury.
Anesthesiology 96:1485-1491, 2002.
291. Homi HM, Yokoo N, Ma D, et al: The neuroprotec-
tive effect of xenon administration during transient
middle cerebral artery occlusion in mice. Anesthe-
siology 99:876-881, 2003.
292. Ma D, Yang H, Lynch J, et al: Xenon attenuates car-
diopulmonary bypass–induced neurologic and
neurocognitive dysfunction in the rat. Anesthesio-
logy 98:690–698, 2003.
293. Ma D, Hossain M, Chow A, et al: Xenon and hypo-
thermia combine to provide neuroprotection from
neonatal asphyxia. Ann Neurol 58:182-193, 2005.
294. Ma D,Hossain M,Rajakumaraswamy N,et al: Com-
bination of xenon and isoflurane produces a syner-
gistic protective effect against oxygen-glucose
deprivation injury in a neuronal-glial co-culture
model. Anesthesiology 99:748-751, 2003.
295. Ma D, Hossain M, Pettet GK, et al: Xenon precon-
ditioning reduces brain damage from neonatal
asphyxia in rats. J Cereb Blood Flow Metab 26:199-
208, 2006.
296. Jevtovic-Todorovic V, Beals J, Benshoff N, et al: Pro-
longed exposure to inhalational anesthetic nitrous
oxide kills neurons in adult rat brain. Neuroscience
122:609-616, 2003.
297. Williamson PB, Ma D, Hossain M, et al: Xenon does
not cause apoptotic neurodegeneration in the neo-
natal rat and protects against isoflurane-induced
apoptosis [abstract]. Anesthesiology 101(Suppl):
A864, 2004.
298. Ravussin P, de Tribolet N: Total intravenous anes-
thesia with propofol for burst suppression in cerebral
aneurysm surgery: Preliminary report of 42 patients.
Neurosurgery 32:236-240, 1993, discussion 240.
Fisiología cerebral y efectos de los anestésicos
103
3
Sección
I
Fisiología y anestesia
© ELSEVIER. Fotocopiar sin autorización es un delito